David Epstein
Fondateur chez BLACK DIAMOND THERAPEUTICS, INC.
Fortune : 5 M $ au 30/04/2024
Postes actifs de David Epstein
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/09/2016 | - |
| Fondateur | 01/01/2014 | - | |
| Directeur Général | 01/09/2016 | 15/09/2023 | |
| President | 01/09/2016 | 15/09/2023 |
Historique de carrière de David Epstein
Anciens postes connus de David Epstein
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| METASTAT, INC. | Directeur/Membre du Conseil | 16/04/2013 | 01/04/2015 |
| Corporate Officer/Principal | 16/04/2013 | 01/04/2015 | |
| OSI PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 07/04/2010 | 31/03/2013 |
Archemix Corp.
 Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Archemix Corp. engages in the research and development of aptamer-based therapeutic products. It focuses in the areas of cardiovascular disease hematology, and oncology. The company was founded in May 2001 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | - | - |
| Fondateur | 01/05/2001 | 01/01/2003 | |
| Corporate Officer/Principal | 01/05/2001 | 01/01/2003 | |
| Duke-NUS Graduate Medical School Singapore | Corporate Officer/Principal | - | - |
Formation de David Epstein
| Lewis & Clark College (Oregon) | Undergraduate Degree |
| Brandeis University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
| Singapour | 2 |
Opérationnelle
| Director/Board Member | 3 |
| Corporate Officer/Principal | 3 |
| Founder | 2 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 3 |
| Producer Manufacturing | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| METASTAT, INC. | Producer Manufacturing |
| BLACK DIAMOND THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
Archemix Corp.
Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Archemix Corp. engages in the research and development of aptamer-based therapeutic products. It focuses in the areas of cardiovascular disease hematology, and oncology. The company was founded in May 2001 and is headquartered in Cambridge, MA. | Commercial Services |
- Bourse
- Insiders
- David Epstein
- Expérience
